Company Description
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide.
Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.
The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them.
It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions.
iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
| Country | United States |
| Founded | 2009 |
| IPO Date | Jun 17, 2021 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 53 |
| CEO | Ms. Tracy Wilson Curley |
Contact Details
Address: 450 Bedford Street, Suite 1010 Lexington, Massachusetts 02420 United States | |
| Phone | 781-301-6700 |
| Website | ispecimen.com |
Stock Details
| Ticker Symbol | ISPC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $8.00 |
| CIK Code | 0001558569 |
| CUSIP Number | 45032V108 |
| ISIN Number | US45032V1089 |
| Employer ID | 27-0480143 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Tracy Wilson Curley | Chief Executive Officer, Chief Financial Officer, Treasurer and Director |
| Benjamin Bielak | Chief Information Officer and Secretary |
| Carly Lejnieks | Vice President of Marketing |
| Annette Arnold | Vice President of Sales and Business Development |
| David Wages M.D., Ph.D. | Chief Medical Officer |
| Eric Langlois | Chief Revenue Officer |
| Evan Cox | Senior Vice President of Strategy and Innovation |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 11, 2024 | 8-K | Current Report |
| Mar 28, 2024 | PRE 14A | Other preliminary proxy statements |
| Mar 26, 2024 | 8-K | Current Report |
| Mar 14, 2024 | 8-K | Current Report |
| Mar 13, 2024 | 10-K | Annual Report |
| Mar 5, 2024 | 8-K | Current Report |
| Mar 5, 2024 | 424B5 | Filing |
| Feb 15, 2024 | 8-K | Current Report |
| Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Dec 21, 2023 | 8-K | Current Report |